Miller Anestesia

4. Takayama Y, Costa KD, Covell JW: Contribution of

laminar myofiber architecture to load-dependent

changes in mechanics of LV myocardium. Am J

Physiol Heart Circ Physiol 282:H1510–H1520, 2002.

5. Katz AM: Structure of the heart. In: Physiology of the

Heart, 3rd ed. Philadelphia, Lippincott-Raven, 2001,

pp 1–38.

6. Opie LH: Heart cells and organelles. In: The Heart.

Physiology from Cell to Circulation, 4th ed. Philadel-

phia, Lippincott-Raven, 2004, pp 42–69.

7. Opie LH: Ventricular function. In: The Heart. Physio-

logy from Cell to Circulation, 4th ed. Philadelphia,

Lippincott-Raven, 2004, pp 355–401.

8. Frank O: Zur Dynamik des Herzmuskels. Z Biol

32:370, 1895.

9. Starling EH: Linacre Lecture on the Law of the Heart.

London, Longmans Green, 1918.

10. Holubarsch C, Ruf T, Goldstein D, et al: Existence of

the Frank-Starling mechanism in the failing human

heart. Circulation 94:683–689, 1996.

11. Katz AM: The working heart. In: Physiology of the

Heart,, 3rd ed. Philadelphia, Lippincott-Raven, 2001,

pp 418–443.

12. LeWinter MM, Osol G: Normal physiology of the

cardiovascular system. In Fuster V (ed): Hurst’s The

Heart,, 10th ed. New York, McGraw-Hill, 2001, pp

63–94.

13. Opie LH: Mechanisms of cardiac contraction and

relaxation. In Braunwald E (ed): Heart Disease,, 6th

ed. Philadelphia, WB Saunders, 2001, pp 443–478.

14. Little WC: Assessment of normal and abnormal

cardiac function. In Braunwald E (ed): Heart Disease,,

6th ed. Philadelphia, WB Saunders, 2001, pp

479–502.

15. Zile MR, Brutsaert DL: New concepts in diastolic

dysfunction and diastolic heart failure. Circulation

105:1387–1393, 2002.

16. Opie LH: Myocardial contraction and relaxation. In:

The Heart. Physiology from Cell to Circulation, 4th

ed. Philadelphia, Lippincott-Raven, 2004, pp

221–245.

17. Roberts R: Principles of molecular cardiology. In

Fuster V (ed): Hurst’s The Heart,, 10th ed. New York,

McGraw-Hill, 2001, pp 95–112.

18. Katz AM: Contractile proteins and cytoskeleton. In:

Physiology of the Heart,, 3rd ed. Philadelphia, Lippin-

cott-Raven, 2001, pp 123–150.

19. Severs NJ: The cardiac muscle cell. Bioessays 22:188–

199, 2000.

20. Yeager M: Structure of cardiac gap junction interce-

llular channels. J Struct Biol 121:231–245, 1998.

21. Severs NJ: Intercellular junctions and the cardiac

intercalated disk. Adv Myocardiol 5:223–242, 1985.

22. Fill M, Copello JA: Ryanodine receptor calcium

release channels. Physiol Rev 82:893–922, 2002.

23. Kumar NM, Gilula NB: The gap junction communi-

cation channel. Cell 84:381–388, 1996.

24. Katz AM: The cardiac action potential. In: Physiology

of the Heart,, 3rd ed. Philadelphia, Lippincott-Raven,

2001, pp 478–516.

25. Katz AM: Calcium fluxes. In: Physiology of the

Heart,, 3rd ed. Philadelphia, Lippincott-Raven, 2001,

pp 232–233.

26. Bers DM: Cardiac excitation-contraction coupling.

Nature 415:198–205, 2002.

27. de Tombe PP: Cardiac myofilaments: Mechanics and

regulation. J Biomech 36:721–730, 2003.

28. Opie LH: Excitation-contraction coupling. In: The

Heart. Physiology from Cell to Circulation, 4th ed.

Philadelphia, Lippincott-Raven, 2004, pp 159–185.

29. Bonne G, Carrier L, Richard P, et al: Familial hyper-

trophic cardiomyopathy, from mutations to functio-

nal defect. Circ Res 83:580–593, 1998.

30. Solaro RJ, Rarick HM: Troponin and tropomyosin.

Circ Res 83:417–480, 1998.

31. Fuchs F, Smith SH: Calcium, cross-bridges, and the

Frank-Starling relationship. News Physiol Sci 16:5–

10, 2001.

32. Trinick J, Tskhovrebova L: Titin: A molecular control

freak. Trends Cell Biol 9:377–380, 1999.

33. Moss RL, Fitzsimons DP: Frank-Starling relationship.

Circ Res 90:11–13, 2002.

34. Alvarez BV, Perez NG, Ennis IL, et al: Mechanisms

underlying the increase in force and Ca

transient

that follow stretch of cardiac muscle.Circ Res 85:716–

722, 1999.

35. Fukuda N, Sasaki D, Ishiwata S, Kurihara S: Length

dependence of tension generation in rat skinned

cardiac muscle. Circulation 104:1639–1645, 2001.

36. Konhilas JP, Irving TC, de Tombe PP: Myofilament

calcium sensitivity in skinned rat cardiac trabeculae.

Circ Res 90:59–65, 2002.

37. Konhilas JP, Irving TC, de Tombe PP: Length-depen-

dent activation in three striated muscle types of the

rat. J Physiol 544:225–236, 2002.

38. Capetanaki Y: Desmin cytoskeleton: A potential regu-

lator of muscle mitochondrial behavior and function.

Trends Cardiovasc Med 12:339–348, 2002.

39. Howard J, Hyman AA: Dynamics and mechanics of

the microtubule plus end. Nature 422:753–758,

2003.

40. Opie LH: Receptors and signal transduction. In: The

Heart. Physiology from Cell to Circulation, 4th ed.

Philadelphia, Lippincott-Raven, 2004, pp 187.

41. Rockman HA, Koch WJ, Lefkowitz RJ: Seven-trans-

membrane-spanning receptors and heart function.

Nature 415:206–212, 2002.

42. Mendelowitz D: Advances in parasympathetic control

of heart rate and cardiac function. News Physiol Sci

14:155–161, 1999.

43. Brodde OE, Michel MC: Adrenergic and muscarinic

receptors in the human heart. Pharm Rev 51:651–689,

1999.

44. Dhein S, Van Koppen CJ, Brodde OE: Muscarinic

receptors in the mammalian heart. Pharm Res

44:161–182, 2001.

45. Kaumann AJ, Molenaar P: Modulation of human

cardiac function through 4

-adrenoceptor popula-

tions. Naunyn Schmiedebergs Arch Pharmacol

355:667–681, 1997.

46. Endoh M: Cardiac

-adrenoceptors that regulate

contractile function: Subtypes and subcellular signal

transduction mechanisms. Neurochem Res 21:217–

229, 1996.

47. Artega GM, Kobayashi T, Solaro RJ: Molecular

actions of drugs that sensitize cardiac myofilaments

to Ca

. Ann Med 34:248–258, 2002.

48. Maisel AS, Scott NA, Motulsky HJ, et al: Elevation of

plasma neuropeptide Y levels in congestive heart

failure. Am J Med 86:43–48, 1989.

49. Grundemar L, Hakanson R: Multiple neuropeptide Y

receptors are involved in cardiovascular regulation.

Peripheral and central mechanisms. Gen Pharmacol

24:785–796, 1993.

50. Henning RJ, Sawmiller DR: Vasoactive intestinal

peptide: Cardiovascular effects. Cardiovasc Res

49:27–37, 2001.

51. de Bold AJ, Bruneau BG, Kuroski de Bold M: Mecha-

nical and neuroendocrine regulation of the endocrine

heart. Cardiovasc Res 31:7–18, 1996.

52. Cameron VA, Ellmers LJ: Minireview: Natriuretic

peptides during development of the fetal heart and

circulation. Endocrinology 144:2191–2194, 2003.

53. Delcayre C, Silvestre JS: Aldosterone and the heart:

Towards a physiological function? Cardiovasc Res

42:7–12, 1999.

54. Martinez A: Biology of adrenomedullin. Microsc Res

Tech 57:1–2, 2002.

55. Schuijt MP, Jan Danser AH. Cardiac angiotensin II:

An intracrine hormone? Am J Hypertens 15:1109–

1116, 2002.

56. Dinh DT, Frauman AG, Johnston CI, Fabiani ME:

Angiotensin receptors: Distribution, signalling and

function. Clin Sci 100:481–492, 2001.

57. Kitamura K, Kangawa K, Eto T: Adrenomedullin and

PAMP: Discovery, structures, and cardiovascular

functions. Microsc Res Tech 57:3–13, 2002.

58. Minamino N, Kikumoto K, Isumi Y: Regulation of

adrenomedullin expression and release. Microsc Res

Tech 57:28–39, 2002.

59. Smith DM, Coppock HA, Withers DJ, et al: Adreno-

medullin: Receptor and signal transduction. Biochem

Soc Trans 30:432–437, 2002.

60. Opie LH, Sack MN: Enhanced angiotensin II activity

in heart failure. Circ Res 88:654–658, 2001.

61. De MelloWC: Cardiac arrhythmias: The possible role

of the renin-angiotensin system. J Mol Med 79:103–

108, 2001.

62. Kramer BK, Ittner KP, Beyer ME, et al: Circulatory

and myocardial effects of endothelin. J Mol Med

75:886–890, 1997.

63. Walker BR, Childs ME, Adamas EM: Direct cardiac

effects of vasopressin: Role of V

and V

vasopressi-

nergic receptors. Am J Physiol 255:H261–H265,

1988.

64. Chandrashekhar Y, Prahash AJ, Sen A, et al: The role

of arginine vasopressin and its receptors in the normal

and failing rat heart. J Mol Cell Cardiol 35:495–504,

2003.

65. Mendelsohn ME: Molecular and cellular basis of car-

diovascular gender differences. Science 308:1583–

1587, 2005.

66. Du XJ, Fang L, Kiriazis H: Sex dimorphism in cardiac

pathophysiology: Experimental findings, hormonal

mechanisms, and molecular mechanisms. Pharmacol

Ther 111:434–475, 2006.

67. Pham TV, Rosen MR: Sex, hormones and repolariza-

tion. Cardiovasc Res 53:740–751, 2002.

68. Parlow JL, Bégou G, Sagnard P, et al: Cardiac baro-

reflex during the postoperative period in patients

with hypertension. Anesthesiology 90:681–692,

1999.

69. Campagna JA, Carter C: Clinical relevance of the

Bezold-Jarisch reflex. Anesthesiology 98:1250–1260,

2003.

70. Huikuri HV, Pikkujamsa SM, Airaksinen KE, et al:

Sex-related differences in autonomic modulation of

heart rate in middle-aged subjects. Circulation

94:122–125, 1996.

71. Keyl C, Schneider A, Hobbhahn J, Bernadi L: Sinusoi-

dal neck suction for evaluation of baroreflex sensiti-

vity during desflurane and sevoflurane anesthesia.

Anesth Analg 95:1629–1636, 2002.

72. Devlin MG,Angus JA,Wilson KM, et al: Acute effects

of L- and T-type calcium channel antagonists on car-

diovascular reflexes in conscious rabbits. Clin Exp

Pharmacol Physiol 29:372–380, 2002.

73. Thomas CJ, Woods RL: Guanylyl cyclase receptors

mediate cardiopulmonary vagal reflex actions of

ANP. Hypertension 41:279–285, 2003.

176

Fisiología y anestesia